To investigate the biology of tumor recurrence we developed a minimally invasive tumor relapse model by genetically engineering an established murine GBM cell line with the HSVTK suicide gene (mGBM-TK cells); the cell death mechanism is activated after ganciclovir (GCV) administration [28,29]. The gene discussed is TKT; the disease is glioblastoma.